Pfizer

Pfizer logo

With our 175-year legacy of helping patients, Pfizer is committed to providing immunoglobulin (Ig) treatment options to patients who rely on them.


Panzyga

Pfizer is proud to support the Ig community with a commitment to helping meet the diverse treatment needs of patients.

Important Safety Information

Indications and Usage

PANZYGA (Immune Globulin Intravenous [Human] – ifas) is indicated for the treatment of primary humoral immunodeficiency (PI) in patients 2 years of age and older, chronic immune thrombocytopenia (cITP) in adults and chronic inflammatory demyelinating polyneuropathy (CIDP) in adults.

PANZYGA is a liquid medicine for infusion that contains immunoglobulin G (IgG), which are proteins that help fight infection. It is made from human plasma that is donated by healthy people and contains antibodies. For patients with PI, PANZYGA helps replace the missing antibodies in the body. For patients with cITP, PANZYGA helps the body maintain more platelets (the blood cells that help blood clot) to control or prevent bleeding. For patients with CIDP, PANZYGA may help improve mobility and hand strength.

PANZYGA is given into a vein (intravenously) in a hospital, infusion center, doctor’s office, or at home by a trained healthcare provider (HCP).

Important Safety Information

Product Description

Pfizer Pledge Warranty Program

Patient Assistance

Patient Videos